(Q37641997)

21 August 2017

1 reference

title

Olfactory dysfunction as a diagnostic marker for Parkinson's disease (English)

1 reference

21 August 2017

0 references

1 reference

1 reference

3

Heinz Reichmann

1 reference

21 August 2017

2

Thomas Hummel

1 reference

21 August 2017

Antje Haehner

1

1 reference

21 August 2017

1 December 2009

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

21 August 2017

1 reference

21 August 2017

9

1 reference

21 August 2017

12

1 reference

21 August 2017

1773-1779

1 reference

Olfactory function in patients with Parkinson's disease

21 August 2017

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Olfactory dysfunction in parkinsonism: A general deficit unrelated to neurologic signs, disease stage, or disease duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Prevalence of smell loss in Parkinson's disease--a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Prevalence of olfactory impairment in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Systematic evaluation of rating scales for impairment and disability in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Diagnostic performance of clinical motor and non-motor tests of Parkinson disease: a matched case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Biopsies of olfactory epithelium in patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Olfactory bulb volumes in patients with idiopathic Parkinson's disease a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Striatal deafferentation increases dopaminergic neurogenesis in the adult olfactory bulb

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Functional imaging of the cerebral olfactory system in patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Regional differences in the severity of Lewy body pathology across the olfactory cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Rapid clinical evaluation of anosmia in children: the Alcohol Sniff Test

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

'Sniffin' sticks': olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

A simple and reliable method for clinical assessment of odor thresholds

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Demographic and cognitive predictors of cued odor identification: evidence from a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

3-OMD and homocysteine plasma levels in parkinsonian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Symptoms and duration of the prodromal phase in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Idiopathic hyposmia as a preclinical sign of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Hyposmia and executive dysfunction as predictors of future Parkinson's disease: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Olfactory loss may be a first sign of idiopathic Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Smell identification ability in twin pairs discordant for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Association of olfactory dysfunction with risk for future Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Sniffing out Parkinson disease: can olfactory testing differentiate parkinsonian disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Olfaction in neurodegenerative disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Olfactory dysfunction in pure autonomic failure: Implications for the pathogenesis of Lewy body diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Olfaction and Parkinson's syndromes: its role in differential diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Olfaction in patients with suspected parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Neuroleptic-induced parkinsonism is associated with olfactory dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Extrapyramidal symptoms in Wilson's disease are associated with olfactory dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Parkinson's disease: clinical features and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Parkinsonism: onset, progression, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Biomarkers for the early detection of Parkinson's and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

Diagnosis and the premotor phase of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.115

21 January 2018

Identifiers

DOI

10.1586/ERN.09.115

1 reference

21 August 2017

1 reference

PubMed ID

19951136